Analysts & consensus figures

                                        Provided by Vara Research

                                        Sell-side analyst coverage

                                        A wide range of sell-side analysts provide coverage of DSM for their clients and the broader market is contributing to the VARA consensus in 2018/19.

                                        Institution Analyst
                                        ABN AMRO Mutlu Gundogan
                                        AllianceBernstein Gunther Zechman
                                        Baader Helvea Laura Lopez Pineda
                                        Bank of America Merrill Lynch Georgia Harris
                                        Barclays Sebastian Satz
                                        Berenberg Bank Sebastian Bray
                                        Citigroup Thomas Wrigglesworth
                                        Credit Suisse Chris Counihan
                                        Davy Research Liz Coen
                                        Deutsche Bank Virginie Boucher-Ferte
                                        Equita Massimo Bonisoli
                                        Goldman Sachs Theodora Lee Joseph
                                        HSBC Martin Evans
                                        JP Morgan Chetan Udeshi
                                        KBC Securities Wim Hoste
                                        Kepler Chevreux Martin R?diger
                                        Macquarie James Knight
                                        Mainfirst Bank Andreas Heine
                                        Morgan Stanley Alexandra Thrum
                                        DeGroof Petercam Fernand de Boer
                                        Redburn Neil Tyler
                                        Société Générale Thomas Swoboda
                                        The Idea Paul Hofman
                                        UBS Andrew Stott

                                        Disclaimer
                                        Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. By providing the names of the analysts, DSM does not imply its endorsement of or concurrence with their reports, conclusions or recommendations. DSM assumes no liability for the accuracy of the information provided by analysts and undertakes no obligation to update this information.

                                        Latest consensus figures

                                        The most recent consensus figures provided by Vara Research are detailed below. The figures are based on the estimates given by the banks that were approached.

                                        Analysts’ consensus Q2 2019 and FY 2019 as at 5 July 2019 (incl. IFRS16)

                                        ? Q2 2018 FY 2018 Q2 2019 (est.) FY?2019?(est.)
                                        Sales (continuing) ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 2,371 9,518
                                        Consensus 2,359 9,267 2,307 9,297
                                        Median ? ? 2,309 9,303
                                        Lowest ? ? 2,275 9,159
                                        Adjusted EBITDA (continuing) ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 446 1,767
                                        Consensus 508 1,822 429 1,704
                                        Median ? ? 432 1,704
                                        Lowest ? ? 393 1,666
                                        Of which estimated?adjusted EBITDA from "Temporary Vitamin Effect" ? ? ? ?
                                        Number of Estimates ? ? - -
                                        Highest ? ? - -
                                        Consensus 110 290 - -
                                        Median ? ? - -
                                        Lowest ? ? - -
                                        Underlying business,?adjusted EBITDA ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 446 1,767
                                        Consensus 398 1,532 429 1,704
                                        Median ? ? 432 1,704
                                        Lowest ? ? 393 1,666
                                        Adjusted EBIT (continuing) ? ? ? ?
                                        Number of Estimates ? ? 13 14
                                        Highest ? ? 310 1,202
                                        Consensus 394 1,345 291 1,142
                                        Median ? ? 291 1,137
                                        Lowest ? ? 273 1,096
                                        Nutrition, Sales ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 1,578 6,362
                                        Consensus 1,555 6,137 1,506 6,134
                                        Median ? ? 1,501 6,125
                                        Lowest ? ? 1,471 6,024
                                        Nutrition,?adjusted EBITDA ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 337 1,332
                                        Consensus 397 1,407 319 1,271
                                        Median ? ? 319 1,262
                                        Lowest ? ? 290 1,243
                                        Of which?adjusted EBITDA from "Temporary Vitamin Effect" ? ? ? ?
                                        Number of Estimates ? ? - -
                                        Highest ? ? - -
                                        Consensus 110 290 - -
                                        Median ? ? - -
                                        Lowest ? ? - -
                                        Nutrition underlying,?adjusted EBITDA ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 337 1,332
                                        Consensus 287 1,117 319 1,271
                                        Median ? ? 319 1,262
                                        Lowest ? ? 290 1,243
                                        Nutrition,?adjusted EBIT ? ? ? ?
                                        Number of Estimates ? ? 13 13
                                        Highest ? ? 254 992
                                        Consensus 328 1,111 235 922
                                        Median ? ? 231 913
                                        Lowest ? ? 218 885
                                        Materials, Sales ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 783 2,983
                                        Consensus 754 2,913 744 2,924
                                        Median ? ? 743 2,922
                                        Lowest ? ? 724 2,841
                                        Materials,?adjusted EBITDA ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 136 549
                                        Consensus 135 512 131 516
                                        Median ? ? 131 517
                                        Lowest ? ? 123 496
                                        Materials,?adjusted EBIT ? ? ? ?
                                        Number of Estimates ? ? 13 13
                                        Highest ? ? 102 413
                                        Consensus 104 383 96 380
                                        Median ? ? 98 383
                                        Lowest ? ? 87 329
                                        Innovation Center, Sales ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 49 214
                                        Consensus 39 172 45 191
                                        Median ? ? 45 188
                                        Lowest ? ? 39 179
                                        Innovation Center,?adjusted EBITDA ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 6 24
                                        Consensus 1 8 4 19
                                        Median ? ? 5 21
                                        Lowest ? ? 1 9
                                        Innovation Center,?adjusted EBIT ? ? ? ?
                                        Number of Estimates ? ? 13 13
                                        Highest ? ? 0 -1
                                        Consensus -6 -14 -2 -8
                                        Median ? ? -2 -7
                                        Lowest ? ? -6 -23
                                        Corporate Activities, Sales ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 20 71
                                        Consensus 11 45 12 49
                                        Median ? ? 11 45
                                        Lowest ? ? 10 45
                                        Corporate Activities,?adjusted EBITDA ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? -23 -95
                                        Consensus -25 -105 -26 -102
                                        Median ? ? -25 -100
                                        Lowest ? ? -27 -110
                                        Corporate Activities,?adjusted EBIT ? ? ? ?
                                        Number of Estimates ? ? 13 13
                                        Highest ? ? -33 -135
                                        Consensus -32 -135 -38 -152
                                        Median ? ? -37 -152
                                        Lowest ? ? -43 -171
                                        Profit for the period, before exceptional items - Continuing Operations ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 241 913
                                        Consensus 306 1,034 214 844
                                        Median ? ? 217 839
                                        Lowest ? ? 192 795
                                        Net EPS before exceptional items -?Continuing Operations ? ? ? ?
                                        Number of Estimates ? ? 15 15
                                        Highest ? ? 1.37 5.34
                                        Consensus 1.73 5.84 1.22 4.88
                                        Median ? ? 1.23 4.87
                                        Lowest ? ? 1.08 4.52

                                        Disclaimer
                                        Consensus earnings estimates are based on earnings projections made by securities analysts who cover DSM. Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. DSM does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. DSM assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimate

                                        Read more

                                        • Results center

                                          All our results, updates, key presentations & AGMs from 2013 to date.

                                        • Share center

                                          DSM's ordinary shares, share performance, share listings, share structure, cumulative preference shares and shareholder base.

                                        This site uses cookies to store information on your computer.

                                        Learn more
                                        吉林快三开奖走势图 六肖中特期期准王中王 打扑克牌二八的技巧 贵州快3开奖今天结果是什么 贝贝通比牛牛官网 宁夏11选5中奖规则 刘伯温四肖中特二四六 华东15选5今天开奖结果 p3是机走势图彩宝网 湖南快乐十分走势图表 江苏体十一选五开奖结果 斗地主2 网络单双游戏 临沂刮刮乐在线购买 上海快3开奖结果公告 内蒙古十一选五开奖结果走势图表